MRKR Insider Trading Activity and SEC Form 4 Filings
MRKR insider trading summary
No open-market insider purchases or sales of Marker Therapeutics, Inc. (MRKR) have been reported on SEC Form 4 in the past 12 months.
Latest MRKR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 23, 2024 | Carmen Chang | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | NEA Partners 16, L.P. | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Forest Baskett | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Ali Behbahani | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | New Enterprise Associates 16, L.P. | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Nea 16 Gp, LLC | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Scott D Sandell | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Anthony A. Florence Jr. | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Paul Edward Walker | Insider | Buy | $1.8M (554,250 @ $3.20) |
| Dec 23, 2024 | Mohamad Makhzoumi | Insider | Buy | $1.8M (554,250 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.